London

Resilience System

Main menu


You are here

Research

Covid-19: Blood Plasma Authorization Is Put on Hold

Last week, just as the Food and Drug Administration was preparing to issue an emergency authorization for blood plasma as a Covid-19 treatment, a group of top federal health officials including Dr. Anthony S. Fauci intervened, arguing that emerging data on the treatment was too weak, according to two senior administration officials.

The authorization is on hold for now as more data is reviewed, according to H. Clifford Lane, the clinical director at the National Institute of Allergy and Infectious Diseases. An emergency approval could still be issued in the near future, he said.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected

 

As the coronavirus pandemic continues to wreak havoc in the United States and treatments are needed more than ever, clinical trials for some of the most promising experimental drugs are taking longer than expected.

Researchers at a dozen clinical trial sites said that testing delays, staffing shortages, space constraints and reluctant patients were complicating their efforts to test monoclonal antibodies, man-made drugs that mimic the molecular soldiers made by the human immune system.

Problem, Solution, SitRep, or ?: 

Study hints, can’t prove, survivor plasma fights COVID-19

Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts worry if, amid clamor for the treatment, they’ll ever get a clear answer.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks